Xylitol, a sugar substitute found in chewing gum, baked goods and toothpaste, was associated with long-term cardiovascular risks in a new study of more than 17,000 adults.

Clinicians who dedicate their lives to helping others may not always take care of their own health, according to new data presented at ESC Congress 2026.

Novartis recalled a single lot of valsartan, a blood pressure/heart failure drug the company sells under the brand name Diovan. According to the FDA, this is a Class II recall.

Cardiac CT scans may give clinicians a way to visualize the effects of environmental exposure before cardiovascular events even occur.

These findings underscore the importance of making healthy lifestyle decisions at a young age. 

The popular diabetes drug, sold by Eli Lilly and Company under the brand name Mounjaro, has been at the center of many cardiology trials over the years. It is the first dual GIP and GLP-1 hormone receptor agonist approved by the FDA for this indication.

There is no question metformin is an effective medication for patients with type 2 diabetes. When it comes to treating heart failure, however, it falls short.

The first-of-its-kind continuous monitoring device from Abbott tracks glucose and ketone levels at the same time. 

Waist circumference and waist-to-hip ratio both provide substantial value when evaluating a patient's risk of developing heart disease. “It is time to abandon a sole focus on BMI,” as Harlan M. Krumholz, MD, explained. 

The FDA has authorized four new flavored nicotine pouches, highlighting their potential to help adults stop smoking cigarettes. The American Heart Association shared its concerns with the move, saying "key questions" remain unanswered.